Article
Author(s):
San Francisco - The known teratogenicity of isotretinoin, as well as a possible link to psychiatric illness, means that physicians prescribing the drug must carefully follow risk-management guidelines. These guidelines are mandated by the FDA.
Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Top 5 Articles of the Week: February 2-7
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
Topical Corticosteroids: Potency, Vehicles, and Best Practices